AKT1 and neoplasm: Thus, dual inhibition of Akt and pERK is beneficial since preclinical studies in several tumor types have shown that dual inhibition of both the PI3K and MEK/ERK pathways leads to greater growth inhibition compared to single pathway inhibition [19].